Surgical and Interventional Therapies for Pulmonary Arterial Hypertension

 

 Buy Article Permissions and Reprints

ABSTRACT

Surgical and interventional therapies for pulmonary arterial hypertension (PAH) in appropriately selected patients have the potential to dramatically improve or, in some cases, cure PAH. These include atrial septostomy, a palliative procedure or bridge to transplantation in patients with refractory right heart failure, pulmonary thromboendarterectomy for pulmonary hypertension associated with chronic thromboembolic disease, and closure of congenital systemic-pulmonary shunts in patients with PAH but without significant pulmonary vascular disease. Lung transplantation should be considered for patients with all forms of PAH who demonstrate advanced or progressive disease.

REFERENCES

• 1 Kerstein D, Levy P S, Hsu D T, Hordof A J, Gersony W M, Barst R J. Blade balloon atrial septogstomy in patients with severe primary pulmonary hypertension.  Circulation. 1995;  91 2028-2035
  PubMedGoogle Scholar
• 2 Allcock R J, O'Sullivan J J, Corris P A. Atrial septostomy for pulmonary arterial hypertension.  Heart. 2003;  89 1344-1347
  CrossrefPubMedGoogle Scholar
• 3 Rich S, Dodin E, McLaughlin V V. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application.  Am J Cardiol. 1997;  80 369-371
  CrossrefPubMedGoogle Scholar
• 4 Reichenberger F, Pepke-Zaba J, McNeil K, Parameshwar J, Shapiro L M. Atrial septostomy in the treatment of severe pulmonary arterial hypertension.  Thorax. 2003;  58 797-800
  CrossrefPubMedGoogle Scholar
• 5 Rothman A, Sklansky M S, Lucas V W et al.. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension.  Am J Cardiol. 1999;  84 682-686
  CrossrefPubMedGoogle Scholar
• 6 Khan M A, Bricker J T, Mullins C E, Yousef S A, Nihill M R, Vargo T A. Blade atrial septostomy: experience with the first 50 procedures.  Cathet Cardiovasc Diagn. 1991;  23 257-262
  PubMedGoogle Scholar
• 7 Sandoval J, Gaspar J, Pulido T et al.. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: a therapeutic alternative for patients nonresponsive to vasodilator treatment.  J Am Coll Cardiol. 1998;  32 297-304
  CrossrefPubMedGoogle Scholar
• 8 Barst R J. Role of atrial septostomy in the treatment of pulmonary vascular disease.  Thorax. 2000;  55 95-96
  CrossrefPubMedGoogle Scholar
• 9 Pengo V, Lensing A W, Prins M H et al.. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.  N Engl J Med. 2004;  350 2257-2264
  CrossrefPubMedGoogle Scholar
• 10 Daily P O, Dembitsky W P, Jamieson S W. The evolution and the current state of the art of pulmonary thromboendarterectomy.  Semin Thorac Cardiovasc Surg. 1999;  11 152-163
  PubMedGoogle Scholar
• 11 Fishman A J, Moser K M, Fedullo P F. Perfusion lung scans vs pulmonary angiography in evaluation of suspected primary pulmonary hypertension.  Chest. 1983;  84 679-683
  PubMedGoogle Scholar
• 12 Ryan K L, Fedullo P F, Davis G B, Vasquez T E, Moser K M. Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension.  Chest. 1988;  93 1180-1185
  CrossrefPubMedGoogle Scholar
• 13 Auger W R, Fedullo P F, Moser K M, Buchbinder M, Peterson K L. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography.  Radiology. 1992;  182 393-398
  PubMedGoogle Scholar
• 14 Straube K R, Dotter C T, O'Dell J. Death following selective right ventricular angiocardiography: a case report.  Radiology. 1963;  80 616-621
  PubMedGoogle Scholar
• 15 Watson H. Severe pulmonary hypertensive episodes following angiocardiography with sodium metrizoate.  Lancet. 1964;  171 732-733
  PubMedGoogle Scholar
• 16 Mills S R, Jackson D C, Older R A, Heaston D K, Moore A V. The incidence, etiologies, and avoidance of complications of pulmonary angiography in a large series.  Radiology. 1980;  136 295-299
  PubMedGoogle Scholar
• 17 Nicod P, Peterson K, Levine M et al.. Pulmonary angiography in severe chronic pulmonary hypertension.  Ann Intern Med. 1987;  107 565-568
  PubMedGoogle Scholar
• 18 Hofmann L V, Lee D S, Gupta A et al.. Safety and hemodynamic effects of pulmonary angiography in patients with pulmonary hypertension: 10-year single-center experience.  AJR Am J Roentgenol. 2004;  183 779-786
  PubMedGoogle Scholar
• 19 Pitton M B, Duber C, Mayer E, Thelen M. Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension.  Circulation. 1996;  94 2485-2491
  CrossrefPubMedGoogle Scholar
• 20 Tardivon A A, Musset D, Maitre S et al.. Role of CT in chronic pulmonary embolism: comparison with pulmonary angiography.  J Comput Assist Tomogr. 1993;  17 345-351
  PubMedGoogle Scholar
• 21 Bergin C J, Sirlin C B, Hauschildt J P et al.. Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation.  Radiology. 1997;  204 695-702
  PubMedGoogle Scholar
• 22 Ley S, Kauczor H U, Heussel C P et al.. Value of contrast-enhanced MR angiography and helical CT angiography in chronic thromboembolic pulmonary hypertension.  Eur Radiol. 2003;  13 2365-2371
  CrossrefPubMedGoogle Scholar
• 23 Kreitner K F, Ley S, Kauczor H U et al.. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques.  Radiology. 2004;  232 535-543
  CrossrefPubMedGoogle Scholar
• 24 Moser K M, Auger W R, Fedullo P F. Chronic major-vessel thromboembolic pulmonary hypertension.  Circulation. 1990;  81 1735-1743
  CrossrefPubMedGoogle Scholar
• 25 Tscholl D, Langer F, Wendler O, Wilkens H, Georg T, Schafers H J. Pulmonary thromboendarterectomy: risk factors for early survival and hemodynamic improvement.  Eur J Cardiothorac Surg. 2001;  19 771-776
  CrossrefPubMedGoogle Scholar
• 26 Gilbert T B, Gaine S P, Rubin L J, Sequeira A J. Short-term outcome and predictors of adverse events following pulmonary thromboendarterectomy.  World J Surg. 1998;  22 1029-1032 discussion 33
  CrossrefPubMedGoogle Scholar
• 27 Barzaghi N, Maurelli M, Emmi V et al.. Pulmonary thromboendarterectomy in a patient with cryoagglutinins.  J Cardiothorac Vasc Anesth. 2000;  14 447-448
  CrossrefPubMedGoogle Scholar
• 28 Yung G L, Channick R N, Fedullo P F et al.. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease.  Am J Respir Crit Care Med. 1998;  157(5 Pt 1) 1690-1693
  PubMedGoogle Scholar
• 29 Jamieson S W, Auger W R, Fedullo P F et al.. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period.  J Thorac Cardiovasc Surg. 1993;  106 116-126 discussion 26-27
  PubMedGoogle Scholar
• 30 Moser K M, Spragg R G, Utley J, Daily P O. Chronic thrombotic obstruction of major pulmonary arteries: results of thromboendarterectomy in 15 patients.  Ann Intern Med. 1983;  99 299-304
  PubMedGoogle Scholar
• 31 Ando M, Okita Y, Tagusari O, Kitamura S, Nakanishi N, Kyotani S. Surgical treatment for chronic thromboembolic pulmonary hypertension under profound hypothermia and circulatory arrest in 24 patients.  J Card Surg. 1999;  14 377-385
  CrossrefPubMedGoogle Scholar
• 32 Menzel T, Wagner S, Kramm T et al.. Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy.  Chest. 2000;  118 897-903
  CrossrefPubMedGoogle Scholar
• 33 Kapitan K S, Clausen J L, Moser K M. Gas exchange in chronic thromboembolism after pulmonary thromboendarterectomy.  Chest. 1990;  98 14-19
  PubMedGoogle Scholar
• 34 Moser K M, Auger W R, Fedullo P F, Jamieson S W. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment.  Eur Respir J. 1992;  5 334-342
  PubMedGoogle Scholar
• 35 Chitwood Jr W R, Sabiston Jr D C, Wechsler A S. Surgical treatment of chronic unresolved pulmonary embolism.  Clin Chest Med. 1984;  5 507-536
  PubMedGoogle Scholar
• 36 Mayer E, Kramm T, Dahm M et al.. Early results of pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension.  Z Kardiol. 1997;  86 920-927
  CrossrefPubMedGoogle Scholar
• 37 Miller Jr W T, Osiason A W, Langlotz C P, Palevsky H I. Reperfusion edema after thromboendarterectomy: radiographic patterns of disease.  J Thorac Imaging. 1998;  13 178-183
  PubMedGoogle Scholar
• 38 Auger W, Fedullo P F, Moser K. In-hospiral mortality has decreased for patients undergoing pulmonary thromboendarterectomy [abstract].  Am J Respir Crit Care Med. 1996;  153 A92
  PubMedGoogle Scholar
• 39 Kerr K M, Auger W R, Marsh J J et al.. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy.  Am J Respir Crit Care Med. 2000;  162 14-20
  PubMedGoogle Scholar
• 40 Mares P, Gilbert T B, Tschernko E M et al.. Pulmonary artery thromboendarterectomy: a comparison of two different postoperative treatment strategies.  Anesth Analg. 2000;  90 267-273
  CrossrefPubMedGoogle Scholar
• 41 Archibald C J, Auger W R, Fedullo P F et al.. Long-term outcome after pulmonary thromboendarterectomy.  Am J Respir Crit Care Med. 1999;  160 523-528
  CrossrefPubMedGoogle Scholar
• 42 Mo M, Kapelanski D P, Mitruka S N et al.. Reoperative pulmonary thromboendarterectomy.  Ann Thorac Surg. 1999;  68 1770-1776 discussion 6-7
  CrossrefPubMedGoogle Scholar
• 43 Feinstein J A, Goldhaber S Z, Lock J E, Ferndandes S M, Landzberg M J. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension.  Circulation. 2001;  103 10-13
  CrossrefPubMedGoogle Scholar
• 44 Reitz B A, Wallwork J L, Hunt S A et al.. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease.  N Engl J Med. 1982;  306 557-564
  CrossrefPubMedGoogle Scholar
• 45 Trulock E P, Edwards L B, Taylor D O, Boucek M M, Keck B M, Hertz M I. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004.  J Heart Lung Transplant. 2004;  23 804-815
  CrossrefPubMedGoogle Scholar
• 46 D'Alonzo G E, Barst R J, Ayres S M et al.. Survival in patients with primary pulmonary hypertension: results from a national prospective registry.  Ann Intern Med. 1991;  115 343-349
  PubMedGoogle Scholar
• 47 Shapiro S M, Oudiz R J, Cao T et al.. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.  J Am Coll Cardiol. 1997;  30 343-349
  CrossrefPubMedGoogle Scholar
• 48 McLaughlin V V, Genthner D E, Panella M M, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.  N Engl J Med. 1998;  338 273-277
  CrossrefPubMedGoogle Scholar
• 49 Maurer J R, Frost A E, Estenne M, Higenbottam T, Glanville A R. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.  Transplantation. 1998;  66 951-956
  PubMedGoogle Scholar
• 50 Hopkins W E, Ochoa L L, Richardson G W, Trulock E P. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.  J Heart Lung Transplant. 1996;  15(1 Pt 1) 100-105
  PubMedGoogle Scholar
• 51 Hopkins W E, Waggoner A D. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome.  Am J Cardiol. 2002;  89 34-38
  PubMedGoogle Scholar
• 52 Kidd L, Driscoll D, Gersony W et al.. Second natural history study of congenital heart defects. results of treatment of patients with ventricular septal defects.  Circulation. 1993;  87(suppl 2) I38-51
  PubMedGoogle Scholar
• 53 Jamieson S W, Stinson E B, Oyer P E et al.. Heart-lung transplantation for irreversible pulmonary hypertension.  Ann Thorac Surg. 1984;  38 554-562
  PubMedGoogle Scholar
• 54 Kramer M R, Marshall S E, Tiroke A, Lewiston N J, Starnes V A, Theodore J. Clinical significance of hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplantation.  J Heart Lung Transplant. 1991;  10 317-321
  PubMedGoogle Scholar
• 55 Levine S M. A survey of clinical practice of lung transplantation in North America.  Chest. 2004;  125 1224-1238
  CrossrefPubMedGoogle Scholar
• 56 Kasimir M T, Seebacher G, Jaksch P et al.. Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation.  Eur J Cardiothorac Surg. 2004;  26 776-781
  CrossrefPubMedGoogle Scholar
• 57 Bando K, Armitage J M, Paradis I L et al.. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension.  J Thorac Cardiovasc Surg. 1994;  108 1056-1065
  PubMedGoogle Scholar
• 58 Boujoukos A J, Martich G D, Vega J D, Keenan R J, Griffith B P. Reperfusion injury in single-lung transplant recipients with pulmonary hypertension and emphysema.  J Heart Lung Transplant. 1997;  16 439-448
  PubMedGoogle Scholar
• 59 Ueno T, Smith J A, Snell G I et al.. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger's syndrome.  Ann Thorac Surg. 2000;  69 381-387
  CrossrefPubMedGoogle Scholar
• 60 Mendeloff E N, Meyers B F, Sundt T M et al.. Lung transplantation for pulmonary vascular disease.  Ann Thorac Surg. 2002;  73 209-217 discussion 17-19
  CrossrefPubMedGoogle Scholar
• 61 Chapelier A, Vouhe P, Macchiarini P et al.. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension.  J Thorac Cardiovasc Surg. 1993;  106 299-307
  PubMedGoogle Scholar
• 62 Whyte R I, Robbins R C, Altinger J et al.. Heart-lung transplantation for primary pulmonary hypertension.  Ann Thorac Surg. 1999;  67 937-941 discussion 41-42
  CrossrefPubMedGoogle Scholar
• 63 Franke U F, Wahlers T, Wittwer T et al.. Heart-lung transplantation is the method of choice in the treatment of patients with end-stage pulmonary hypertension.  Transplant Proc. 2002;  34 2181-2182
  CrossrefPubMedGoogle Scholar
• 64 Sharples L D, Tamm M, McNeil K, Higenbottam T W, Stewart S, Wallwork J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation: early risk factors.  Transplantation. 1996;  61 560-566
  CrossrefPubMedGoogle Scholar
• 65 Goetzmann L, Scheuer E, Naef R et al.. Psychosocial situation and physical health in 50 patients > 1 year after lung transplantation.  Chest. 2005;  127 166-170
  CrossrefPubMedGoogle Scholar
• 66 Gross C R, Savik K, Bolman III R M, Hertz M I. Long-term health status and quality of life outcomes of lung transplant recipients.  Chest. 1995;  108 1587-1593
  CrossrefPubMedGoogle Scholar
• 67 TenVergert E M, Essink-Bot M L, Geertsma A, van Enckevort P J, de Boer W J, van der Bij W. The effect of lung transplantation on health-related quality of life: a longitudinal study.  Chest. 1998;  113 358-364
  CrossrefPubMedGoogle Scholar
• 68 Grossman W. Grossman's Cardiac Catherization, Angiography, and Intervention. 6th ed. Philadelphia, PA; Lippincott Williams and Wilkins 2000
  Google Scholar
• 69 Moodie D S, Sterba R. Long-term outcomes excellent for atrial septal defect repair in adults.  Cleve Clin J Med. 2000;  67 591-597
  PubMedGoogle Scholar
• 70 Gersony W M, Rosenbaum M S. Congenital Heart Disease in the Adult. New York, NY; McGraw-Hill 2002
  Google Scholar
• 71 Wu J C, Child J S. Common congenital heart disorders in adults.  Curr Probl Cardiol. 2004;  29 641-700
  PubMedGoogle Scholar
• 72 Walker R E, Moran A M, Gauvreau K, Colan S D. Evidence of adverse ventricular interdependence in patients with atrial septal defects.  Am J Cardiol. 2004;  93 1374-1377, A6
  CrossrefPubMedGoogle Scholar
• 73 Cherian G, Uthaman C B, Durairaj M et al.. Pulmonary hypertension in isolated secundum atrial septal defect: high frequency in young patients.  Am Heart J. 1983;  105 952-957
  CrossrefPubMedGoogle Scholar
• 74 Berger F, Vogel M, Kramer A et al.. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery.  Ann Thorac Surg. 1999;  68 75-78
  CrossrefPubMedGoogle Scholar
• 75 Horvath K A, Burke R P, Collins Jr J J, Cohn L H. Surgical treatment of adult atrial septal defect: early and long-term results.  J Am Coll Cardiol. 1992;  20 1156-1159
  PubMedGoogle Scholar
• 76 Gatzoulis M A, Freeman M A, Siu S C, Webb G D, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults.  N Engl J Med. 1999;  340 839-846
  CrossrefPubMedGoogle Scholar
• 77 Silversides C K, Siu S C, McLaughlin P R et al.. Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients.  Heart. 2004;  90 1194-1198
  CrossrefPubMedGoogle Scholar
• 78 Masura J, Gavora P, Formanek A, Hijazi Z M. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience.  Cathet Cardiovasc Diagn. 1997;  42 388-393
  CrossrefPubMedGoogle Scholar
• 79 Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders.  J Am Coll Cardiol. 2005;  45 505-507
  CrossrefPubMedGoogle Scholar
• 80 Chessa M, Carminati M, Butera G et al.. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect.  J Am Coll Cardiol. 2002;  39 1061-1065
  CrossrefPubMedGoogle Scholar
• 81 Steele P M, Fuster V, Cohen M, Ritter D G, McGoon D C. Isolated atrial septal defect with pulmonary vascular obstructive disease: long-term follow-up and prediction of outcome after surgical correction.  Circulation. 1987;  76 1037-1042
  PubMedGoogle Scholar
• 82 John Sutton M G, Tajik A J, McGoon D C. Atrial septal defect in patients ages 60 years or older: operative results and long-term postoperative follow-up.  Circulation. 1981;  64 402-409
  PubMedGoogle Scholar
• 83 Murphy J G, Gersh B J, McGoon M D et al.. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years.  N Engl J Med. 1990;  323 1645-1650
  PubMedGoogle Scholar
• 84 Andersen M, Lyngborg K, Moeller I, Wennevold A. The natural history of small atrial septal defects: long-term follow-up with serial heart catheterizations.  Am Heart J. 1976;  92 302-307
  PubMedGoogle Scholar
• 85 Neutze J M, Ishikawa T, Clarkson P M, Calcer A L, Barratt-Boyes B G, Kerr A R. Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance.  Am J Cardiol. 1989;  63 327-331
  CrossrefPubMedGoogle Scholar
• 86 Kirklin J W, DuShane J W. Indications for repair of ventricular septal defects.  Am J Cardiol. 1963;  12 75-79
  CrossrefPubMedGoogle Scholar
• 87 Knauth A L, Lock J E, Perry S B et al.. Transcatheter device closure of congenital and postoperative residual ventricular septal defects.  Circulation. 2004;  110 501-507
  CrossrefPubMedGoogle Scholar
• 88 Holzer R, Balzer D, Cao Q L, Lock K, Hijazi Z M. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry.  J Am Coll Cardiol. 2004;  43 1257-1263
  CrossrefPubMedGoogle Scholar

Ramona L DoyleM.D. 

Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine

Rm H-3137, MC 5236, 300 Pasteur Dr.

Stanford, CA 94305

Email: rldoyle@stanford.edu